Press Releases

2015

News Archives: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2015/12/15
WuXi Healthcare Ventures II, L.P. Closes With Oversubscription

2015/12/13
WuXi PharmaTech Presents 2015 Life Science and Chemistry Awards

2015/12/10
WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private Transaction

2015/12/08
WuXi PharmaTech and PRA Health Sciences Restructure Relationship in China

2015/12/07
Dr. Ge Li Receives Executive of the Year Award from SCRIP

2015/11/11
ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction

2015/11/10
WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China

2015/11/05
WuXi PharmaTech Congratulates Novira Therapeutics

2015/11/03
WuXi PharmaTech Announces Third-Quarter 2015 Results

2015/10/29
Gilead Sciences and WuXi PharmaTech Announce Collaboration for a Dedicated Analytical and Stability Testing Facility

2015/10/23
WuXi PharmaTech Launches Medical Device Testing Services in China

2015/10/19
Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi AppTec Headquarters in Shanghai

2015/10/16
WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

2015/10/13
WuXi PharmaTech Launches Mobile OncoWuXi, the World's First App for Accessing Oncology Models

2015/09/17
WuXi PharmaTech Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

2015/08/27
WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

2015/08/26
WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm

2015/08/14
WuXi Pharmatech Enters Into Definitive Merger Agreement

2015/08/10
WuXi PharmaTech and TruTag Technologies Complete Successful Testing of Edible On-Dose Authentication Solution for Pharmaceuticals

2015/07/10
WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement

2015/05/21
WuXi Launches e-Commerce Platform for Chemistry Products

2015/05/21
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

2015/04/30
WuXi PharmaTech Announces Receipt of Proposal

2015/04/23
WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release

2015/04/22
Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine

2015/04/08
Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai

2015/04/02
WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

2015/03/27
Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA

2015/03/12
WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies

2015/03/05
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results

2015/02/27
WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

2015/02/17
WuXi PharmaTech Enters into Syndicated Loan Agreement

2015/02/13
WuXi PharmaTech Schedules Fourth-Quarter 2014 Earnings Release

2015/02/06
WuXiPRA Appoints Two Key Executives

2015/01/30
WuXi PharmaTech's Small-Molecule Manufacturing Subsidiary STA Wins CMO Leadership Award

2015/01/09
WuXi PharmaTech Provides Update of 2014 Financial Guidance, to Present at J.P. Morgan Healthcare Conference

2015/01/05
WuXi Launches Mobile App to Enable Chemistry-on-the-Go